Literature DB >> 33037108

Asbestos and ovarian cancer: examining the historical evidence.

Brian Slomovitz1,2, Christopher de Haydu3, Michael Taub4, Robert L Coleman5, Bradley J Monk6,7.   

Abstract

Asbestos recently returned to the spotlight when Johnson & Johnson halted sales of baby powder due to lawsuits claiming that the talc in baby powder may have been contaminated with asbestos, which has been linked to the risk of ovarian cancer development. Although talc and asbestos have some structural similarities, only asbestos is considered causally associated with ovarian cancer by the WHO's International Agency for Research on Cancer. While it is useful to understand the types and properties of asbestos and its oncologic biology, the history of its association with ovarian cancer is largely based on retrospective observational studies in women working in high asbestos exposure environments. In reviewing the literature, it is critical to understand the distinction between associative risk and causality, and to examine the strength of association in the context of how the diagnosis of ovarian cancer is made and how the disease should be distinguished from a similar appearing but unrelated neoplasm, malignant mesothelioma. Based on contextual misinterpretation of these factors, it is imperative to question the International Agency for Research on Cancer's assertion that asbestos has a clear causal inference to ovarian cancer. This has important clinical implications in the way patients are conceivably counseled and provides motivation to continue research to improve the understanding of the association between asbestos and ovarian cancer. © IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  abdominal neoplasms; female; genital neoplasms; ovarian cancer

Mesh:

Substances:

Year:  2020        PMID: 33037108     DOI: 10.1136/ijgc-2020-001672

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  Frequency of Asbestos Exposure and Histological Subtype of Ovarian Carcinoma.

Authors:  Pauline Vidican; Olivia Perol; Joëlle Fevotte; Emmanuel Fort; Isabelle Treilleux; Elodie Belladame; Jiri Zavadil; Béatrice Fervers; Barbara Charbotel
Journal:  Int J Environ Res Public Health       Date:  2022-04-28       Impact factor: 4.614

Review 2.  What is new about ovarian malignancies?

Authors:  Kinga Grabska; Izabela Pilarska; Marta Magdalena Fudalej; Andrzej Deptała; Anna Badowska-Kozakiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2021-12-29

3.  Analysis of Mortality from Asbestos-Related Diseases in Brazil Using Multiple Health Information Systems, 1996-2017.

Authors:  Eduardo Algranti; Vilma S Santana; Felipe Campos; Leonardo Salvi; Cézar A Saito; Franciana Cavalcante; Heleno R Correa-Filho
Journal:  Saf Health Work       Date:  2022-05-06

4.  Malignant peritoneal mesothelioma literature review: past, present, and future.

Authors:  Stephanie N Gregory; A Leila Sarvestani; Andrew M Blakely
Journal:  Dig Med Res       Date:  2022-06-30

5.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

6.  Sex-Specific Mortality from Asbestos-Related Diseases, Lung and Ovarian Cancer in Municipalities with High Asbestos Consumption, Brazil, 2000-2017.

Authors:  Cézar Akiyoshi Saito; Marco Antonio Bussacos; Leonardo Salvi; Carolina Mensi; Dario Consonni; Fernando Timoteo Fernandes; Felipe Campos; Franciana Cavalcante; Eduardo Algranti
Journal:  Int J Environ Res Public Health       Date:  2022-03-19       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.